Inhaler devices in infants and children: Challenges and solutions

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 17, Issue 2, 2004, Pages 186-195

  Everard, Mark L ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INSULIN;

BODY WEIGHT; BREATHING PATTERN; CHILD; COGNITION; CONFERENCE PAPER; DOSE CALCULATION; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; FUNCTIONAL ANATOMY; HUMAN; INFANT; INHALER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PEDIATRICS; PHYSIOLOGY; SAFETY; TIDAL VOLUME;

ADMINISTRATION, INHALATION; AEROSOLS; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; FORECASTING; HUMANS; INFANT; MALE; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; RISK FACTORS;

EID: 3242687759     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/0894268041457129     Document Type: Conference Paper

References (79)

1. Ad Hoc Committee on Health Literacy for the Council of Scientific Affairs, American Medical Association. 1999. Health literacy: report of the Council of Scientific Affairs. J.A.M.A. 281:552-557.
2. Armitage, J.M., and S.J. Williams. 1988. Inhaler technique in the elderly. Age Ageing 17:275-278.
3. Chapman, K.R., L. Love, and H. Brubaker. 1993. A comparison of breath-actuated and conventional metered-dose inhalation technique in elderly subjects. Chest 104:1332-1337.
4. Goodman, D.E., E. Israel, M. Rosenburg, et al. 1994. The influence of age, diagnosis and gender on proper use of metered-dose inhalers. Am. J. Crit. Care Med. 150:1256-1261.
5. Haahtela, T., T. Klaukka, K. Koskela, et al. 2001. Asthma programme in Finland: a community problem needs community solutions. Thorax 56:806-814.
6. Gonda, I., M. Fiore, E.T. Johannsson, et al. 1999. Bolus delivery of morphine solutions with AERx pain management system. J. Aerosol Med. 12:114.
7. Skyler, J.S., W.T. Cefalu, I.A. Kourides, et al. 2001. Efficiency of inhaled human insulin in type 1 diabetes: a randomized proof-of-concept study. Lancet 357:331-335.
8. Morrow-Brown, H., G. Storey, and W.H.S. George. 1972. Beclomethasone diproprionate: a new steroid aerosol for the treatment of allergic asthma. Br. Med J. 2:585-590.
9. Caplan, C., C. MacArthur, D. Stephens, et al. 1997. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systematic review of the literature. J All Clin Immunol 100:452-457.
10. Milgrom, H., B. Bender, L. Ackerson, et al. 1996. Noncompliance and treatment failure in children with asthma. J. Allergy Clin. Immunol. 98:1051-1057.
11. Gibson, N.A., A.E. Ferguso, T.C. Aitchison, et al. 1995. Compliance with inhaled asthma medication in preschool children. Thorax. 50:1274-1279.
12. van der Palen, J., J.J. Klein, and M.M. Rovers. 1997. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur. Respir. J. 10:652-657.
13. Bauman, L.J., E. Wrigh, E. Leickly, et al. 1994. Relationship of adherence to paediatric asthma morbidity among inner-city children. Pediatrics 110:6-12.
14. Lanes, S.F., L.A. Garcia Rodriguez, and C. Huerta. Respiratory medications and risk of asthma death. Thorax 57:683-686.
15. Jonasson, G., K.-H. Carlsen, and P. Mowinckel. 2000. Asthma drug adherence in a long term clinical trial. Arch. Dis. Child. 83:330-333.
16. Cochrane, G.M., R. Horne, and P. Chanez. 1999. Compliance in asthma. Respir. Med. 93:763-769.
17. Bosley, C.M., J.A. Fosbury, and G.M. Cochrane. 1995. The psychological factors associated with poor compliance with treatment in asthma. Eur. Respir. J. 8:899-904.
18. Braunstein, G.L., G. Trinquet, and A.E. Harper. 1996. Compliance with nedocromil sodium and a nedocromil sodium/salbutamol combination. Eur. Respir. J. 9:893-898.
19. Katsara, M., S. Ritson, and M.L. Everard. 2003. Exhaled nitric oxide (eNO) is not a reliable indicator of compliance amongst asthmatic patients. Am. J. Respir. Crit. Care Med. 167:A208.
20. Nides, M.A., D.P. Tashkin, M.S. Simmons, et al. 1993. Improving inhaler adherence in a clinical trial through the use of a nebulizer chronolog. Chest 104:1332-1337.
21. Saunders, K.B. 1965. Misuse of inhaled bronchoilator agents. Br. Med. J. 1:1037-1038.
22. Crompton, G. 1982. Problems patients have using pressurized aerosol inhalers. Eur J Respir. Dis. 63:101-104.
23. Kamps, A.W.A., B van Ewijk, R.J. Roorda, et al. 2000. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr. Pulmonol. 29:39-42.
24. Giraud, V., and N. Roche. 2002. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur. Respir. J. 19:246-251.
25. Hanania, N.A., R. Wittman, S. Kesten, et al. 1994. Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacer chambers and breath actuated dry powder inhalers. Chest 105:111-116.
26. Tsang, K.W.T., W.-K. Lam, M. Ip, et al. 1997. Inability of physicians to use metered dose inhalers. J. Asthma 34:493-498.
27. Thompson, J., T. Irvine, K. Grathwohl, et al. 1994. Misuse of metered-dose inhalers in hospitalized patients. Chest 105:715-717.
28. O'Callaghan, C., O. Nerbrink, and M.T. Vidgren. 2001. The History of Inhaled Drugs. Marcel Decker, New York.
29. Brennan, V., and M.L. Everard. 2002. Contrivance - a major cause for failure of aerosol therapy in children. Eur. Respir. J. 20:429s.
30. Everard, M.L. 2000. CFC transition: the Emperor's new clothes. Thorax 55:811-814.
31. Shim, C. 2000. Spacer disuse. Am J Respir Crit Care Med 161:A320.
32. Becquiem, M.H., D.L. Swift, A. Bouchikhi, et al. 1991. Particle deposition and resistance in the noses of adults and children. Eur. Respir. J. 4:694-702.
33. Knight, V., C.P. Yu, B.E. Gilbert, et al. 1988. Estimating the dosage of ribavirin aerosol according to age and other variables. J. Infect. Dis. 158:443-448.
34. Morrow, P.E., and C.P. Yu. 1993. Models of aerosol behavior in airways and alveoli. In F. Moren, M.B. Dolovich, M.T. Newhouse, et al., eds. Aerosols in Medicine: Principles, Diagnosis and Therapy, 2nd ed. Elsevier Science, Amsterdam, 157-193.
35. Xu, J.B., and C.P. Yu. 1986. The effects of age on deposition of inhaled aerosols in the human lung. Aerosol Sci. Technol. 5:349-357.
36. Hofmann, W., T.B. Martonen, and R.C. Graham. 1989. Predicted deposition of non-hydroscopic aerosols in the human lung as a function of age. J. Aerosol Med. 2:49-68.
37. Phalen, R.F., and M.J. Oldham. 2001. Methods for modeling particle deposition as a function of age. Respir Physiol 128:119-130.
38. Harvey, R.P., and D.M. Hamby. 2002. Age-specific uncertainty in particulate deposition for 1 microm AMAD particles using the ICRP 66 lung model. Health Phys. 82:807-816.
39. Schiller-Scotland, C.F., R. Hlawa, and J. Gebhart. 1994. Experimental data for total deposition in the respiratory tract of children. Toxicol. Lett. 72:137-144.
40. Nerbrink, O.L., M. Lindstrom, L. Meurling, et al. 2002. Inhalation and deposition of nebulized sodium cromoglycate in two different particle size distributions in children with asthma. Pediatr. Pulmonol. 34:351-360.
41. Becquiem, M.H., D.L. Swift, A. Bouchikhi, et al. 1991. Particle depositions and resistance in the noses of adults and children. Eur. Respir. J. 4:694-702.
42. Coates, A.L., P.D. Allen, C.F. MacNeish, et al. 2001. Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Chest 119:1123-1130.
43. Amirav, I., I. Balanov, M. Gorenberg, et al. 2002. Beta-agonist aerosol distribution in respiratory syncytial virus bronchiolitis in infants. J. Nucl. Med. 43:487-491.
44. Marshall, L.M., P.W. Francis, and F.A. Khafagi. 1994. Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizer. J. Paediatr. Child. Health 30:65-67.
45. Chua, H.L., G.C. Collis, A.M. Newbury, et al. 1994. The influence of age on aerosol deposition in children with cystic fibrosis. Eur. Respir. J. 7:2185-2191.
46. Tal, A., H. Golan, and M. Aviram. 1996. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J. Pediatr. 128:479-484.
47. Fok, T., S. Monkman, and M. Dolovich. 1996. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Paediatr. Pulmonol. 21:3101-3109.
48. Tal, A., H. Golan, N. Grauer, et al. 1996. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J. Pediatr. 128:479-484.
49. Murakam, G., T. Igarashi, and Y. Adachi. 1990. Measurement of bronchial hyperactivity in infants and preschool children using a new method. Ann. Allergy 64:383-387.
50. Mallol, J., S. Rattray, G. Walker, et al. 1996. Aerosol deposition in infants with cystic fibrosis. Pediatr. Pulmonol. 21:276-281.
51. Devadason, S.G., M.L. Everard, C. MacEarlan, et al. 1997. Lung deposition from the Turbuhaler in children with cystic fibrosis. Eur. Respir. J. 10:2023-2028.
52. Diot, P., I.B. Palmer, A. Smaldone, et al. 1997. RhD-Nase I aerosol deposition and related factors in cystic fibrosis. Am. J. Respir. Crit. Care Med. 156:1662-1668.
53. Wildhaber, J.H., N.D. Dore, J.M. Wilson, et al. 1999. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J. Pediatr. 135:28-33.
54. Zar, H.J., E.G. Weinburg, H.J. Binns, et al. 2000. Lung deposition of aerosol - a comparison of different spacers. Arch. Dis. Child. 82:465-468.
55. Devadason, S.G., T. Huang, S. Walker, et al. 2003. Distribution of technetium-99m-labeled QVAR delivered using an Autohaler device in children. Eur. Respir. J. 21:1007-1011.
56. Salmon, B., N.M. Wilson, and M. Silverman. 1990. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch. Dis. Child. 65:401-403.
57. Iles, R., P. Lister, and A.T. Edmunds. 1999. Crying significantly reduces absorption of aerosolized drug in infants. Arch. Dis. Child. 81:163-165.
58. Dequin, P.F., F. Faurisson, E. Lemarie, et al. 2001. Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis. Eur. Respir. J. 18:316-322.
59. Onhoj, J., L. Thorsson, and H. Bisgaard. 2000. Lung deposition of inhaled drugs increases with age. Am. J. Respir. Crit. Care Med. 162:1819-1822.
60. Everard, M.L., and M.B. Dolovich. 2001. In vivo measurements of lung dose. In Bisgaard, H., C. O′-Callaghan, and G. Smaldone, eds. Drug Delivery to the Lung: Clinical Aspects. Marcel Decker, New York, pp. 173-210.
61. Everard, M.L. 1994. The use of radiolabeled aerosols for research purposes in paediatric patients: ethical and practical aspects. Thorax 49:1259-1266.
62. Everard, M.L., J.G. Hardy, and A.D. Milner. 1993. Comparison of nebulized aerosol deposition in the lungs of health adults following oral and nasal inhalation. Thorax 48:1045-1046.
63. Dolovich, M.B., and M.L. Everard. 2001. Inhalation devices and techniques. In Naspitz, C.K., S.J. Szefler, D. Tinkleman, et al., eds. Pediatric Asthma: An International Perspective. Martin Dunitz, London, pp. 327-366.
64. Friegang, B. 1977. New method of beclomethasone aerosol administration to children under 4 years of age. Can. Med. Assoc. J. 117:1308-1309.
65. Everard, M.L., A.R. Clark, and A.D. Milner. 1992. Drug delivery from jet nebulizers. Arch. Dis. Child. 67:586-591.
66. Amirav, I., and M.T. Newhouse. 2001. Aerosol therapy with valved holding chamber in young children: importance of the facemask seal. Pediatrics 108:386-394.
67. Amirav, I., I. Balanov, M. Gorenberg, et al. 2003. Nebulizer hood compared to mask in wheezy infants. Arch. Dis. Child. 88:719-723.
68. Nikander, K. 1997. Adaptive aerosol delivery: the principles. Eur. Respir. Rev. 7:385-387.
69. Goren, A., N. Noviski, A. Avital, et al. 1994. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Pediatr. Pulmonol. 18:77-80.
70. Larberge, S., S. Spier, S.P. Drblick, et al. 1994. Comparison of inhaled terbutaline administered by either the Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma. J. Pediatr. 124:815-817.
71. Iqbal, S.M., S. Ritson, H. Buck, et al. 2003. The majority of children aged 3 years and above can reliably inhale through the clickhaler. Pediatr. Pulmonol. 36:63-68.
72. Gleeson, J.G., and J.F. Price. 1988. Nebuhaler technique. Br. J. Dis. Chest. 82:172-174.
73. Everard, M.L., A. Swarbrick, and A.D. Milner. 2001. Effects of Ribavirin on respiratory morbidity and bronchial responsiveness during the first year post acute bronchiolitis. Respir. Med. 95:275-278.
74. Thorsson, L., and S. Edsbacker. 1998. Lung deposition from a pressurized metered dose inhaler attached to a spacer. Eur. Respir. J. 12:1340-1345.
75. Borgstrom, L., T. Bengtsson, E. Derom, et al. 2000. Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler. Int. J. Pharm. 193:227-230.
76. Aswania, O., S. Ritson, S.M. Iqbal, et al. Intra-subject variability in lung dose in healthy volunteers using five conventional portable inhalers. J. Aerosol. Med. (in press).
77. Janssens, H.M., S.G. Devadason, W.C.J. Hop, et al. 1999. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur. Respir. J. 13:787-791.
78. Mell, A., A. Himmelmann, J. Jendle, et al. 2001. Pharmacokinetics and intra-subject variability of inhaled insulin in healthy smokers and non-smokers. Diabetes 50:A126.
79. Iqbal, S., S. Ritson, I. Prince, et al. 2003. Drug delivery and adherence in young children. Pediatr. Pulmonol. 37:311-317.